Contrasting NantHealth (NH) and Its Rivals
NantHealth (NASDAQ: NH) is one of 20 publicly-traded companies in the “Medical Software & Technology Services” industry, but how does it compare to its rivals? We will compare NantHealth to related businesses based on the strength of its valuation, institutional ownership, profitability, risk, dividends, analyst recommendations and earnings.
This is a summary of recent ratings and target prices for NantHealth and its rivals, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Valuation and Earnings
This table compares NantHealth and its rivals revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|NantHealth||$100.38 million||-$184.10 million||-1.73|
|NantHealth Competitors||$413.57 million||-$24.55 million||395.79|
NantHealth’s rivals have higher revenue and earnings than NantHealth. NantHealth is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Volatility & Risk
NantHealth has a beta of -1.51, indicating that its share price is 251% less volatile than the S&P 500. Comparatively, NantHealth’s rivals have a beta of 1.02, indicating that their average share price is 2% more volatile than the S&P 500.
Institutional and Insider Ownership
7.1% of NantHealth shares are owned by institutional investors. Comparatively, 62.9% of shares of all “Medical Software & Technology Services” companies are owned by institutional investors. 58.0% of NantHealth shares are owned by company insiders. Comparatively, 24.5% of shares of all “Medical Software & Technology Services” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
This table compares NantHealth and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
NantHealth rivals beat NantHealth on 8 of the 12 factors compared.
NantHealth Company Profile
NantHealth, Inc. is a healthcare cloud-based information technology (IT) company. The Company is engaged in converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care. The Company offers the Genomic Proteomic Spectrometry (GPS) Cancer test, a molecular test and decision support solution that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. The Company also offers Nant Operating System (NantOS) and NantOS applications to healthcare providers and payors, self-insured employers and biopharmaceutical companies. It offers CLINICS, an integrated solution that includes GPS Cancer, NantOS and the NantOS applications. The CLINICS solution includes System Infrastructure, Knowledge Platform, Provider Platform and Payor Platform.
Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with MarketBeat.com's FREE daily email newsletter.